Linezolid: all 76 studies that test it
Page 1 of 1. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- Oral Antibiotic Pharmacokinetics in Young InfantsNot yet recruitingNCT07815613Phase 4
- Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TBRecruitingNCT07672405Phase 2
- Microbiological Characteristics of Biofilm on Double J Ureteral Stents After Lithotripsy.Not yet recruitingNCT07301294Phase 4
- Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary InfectionEnrolling by invitationNCT07228702Phase 1
- Optimizing Linezolid Dosing in Patients With Advanced Renal Impairment: a Therapeutic Drug Monitoring-based EvaluationNot yet recruitingNCT07138521Phase 4
- Ultra-Short Regimen for Elderly DS-TBNot yet recruitingNCT07076225Phase 3
- Linezolid Plus Standard of CareRecruitingNCT06958835Not applicable
- Comprehensive Ambulatory Antibiotics for the Treatment of Congenital SyphilisRecruitingNCT06921213Phase 2
- A PAN-USR TB Multi-Center TrialRecruitingNCT06905522Phase 3
- Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric ProphylaxisRecruitingNCT06709196Phase 4
- Model-informed Precision Dosing for LinezolidNot yet recruitingNCT06444802Phase 3
- Program for Rifampicin-Resistant Disease With Stratified Medicine for TuberculosisRecruitingNCT06441006Phase 2/3
- Trial of Novel Regimens for the Treatment of Pulmonary TuberculosisRecruitingNCT06192160Phase 2
- Platform Assessing Regimens and Durations In a Global Multisite Consortium for TBRecruitingNCT06114628Phase 2
- Linezolid or Vancomycin Surgical Site Infection ProphylaxisRecruitingNCT05571722Phase 4
- Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)RecruitingNCT05534750Phase 2
- Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective EndocarditisRecruitingNCT05398679Phase 4
- Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous MeningitisRecruitingNCT05383742Phase 2
- Finding the Optimal Regimen for Mycobacterium Abscessus TreatmentRecruitingNCT04310930Phase 2/3
- Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary TuberculosisActive, not recruitingNCT06058299Phase 2Results posted
- Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)TerminatedNCT05156437Phase 4Results posted
- Linezolid Dosing Strategies in Drug-Resistant TBCompletedNCT05007821Phase 2Results posted
- Adjunctive Linezolid for the Treatment of Tuberculous MeningitisCompletedNCT04021121Phase 2Results posted
- Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant TuberculosisCompletedNCT03086486Phase 3Results posted
- Treatment Shortening of MDR-TB Using Existing and New DrugsCompletedNCT02619994Phase 2Results posted
- A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TBCompletedNCT02333799Phase 3Results posted
- Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin InfectionsTerminatedNCT01619410Not applicableResults posted
- Bioequivalence Study Comparing Linezolid 600 Mg Oral Suspension With 600 Mg Tablet In Chinese Healthy Male SubjectsCompletedNCT01055769Phase 1Results posted
- A Study To Assess The Effect Of Linezolid On QTc IntervalCompletedNCT00795145Phase 1Results posted
- Linezolid to Treat Extensively-Drug Resistant TuberculosisCompletedNCT00727844Phase 2Results posted
- TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TBCompletedNCT00664313Phase 1/2Results posted
- Pharmacokinetics of Linezolid in Children With Cystic FibrosisCompletedNCT00625703Phase 2Results posted
- Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary TuberculosisCompletedNCT00396084Phase 1/2Results posted
- Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream InfectionsTerminatedNCT00108433Phase 3Results posted
- Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)CompletedNCT00087490Phase 4Results posted
- Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)CompletedNCT00084266Phase 4Results posted
- Innovating Shorter, All- Oral, Precised Treatment Regimen for Rifampicin Resistant Tuberculosis：BDLL Chinese CohortActive, not recruitingNCT06649721Phase 3
- Efficacy and Safety of Continuous Versus Intermittent Linezolid Infusion in Critically Ill Patients With Septic ShockStatus unknownNCT05813951Not applicable
- Repurposing Clinically Approved Drugs for Yaws With an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)CompletedNCT05764876Phase 3
- Linezolid for Syphilis Pilot StudyActive, not recruitingNCT05548426Phase 2
- Alternative Antibiotics for SyphilisCompletedNCT05069974Phase 3
- Modified BPaL Regimen for Managing Pre-XDR TB and MDR (TI/NR) TB in IndiaActive, not recruitingNCT05040126Phase 3
- Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUSCompletedNCT04717908Not applicable
- Economic Evaluation of New MDR TB RegimensCompletedNCT04207112Phase 2/3
- Linezolid, Aspirin and Enhanced Dose Rifampicin in HIV-TBMCompletedNCT03927313Phase 2
- Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)CompletedNCT03896685Phase 3
- Linezolid in Healthy VolunteersStatus unknownNCT03841721Phase 1
- Efficacy and Tolerability of Bedaquiline, Delamanid, Levofloxacin, Linezolid, and Clofazimine to Treat MDR-TBActive, not recruitingNCT03828201Phase 2
- Pharmacokinetic Study of Linezolid for TB MeningitisCompletedNCT03537495Phase 2
- Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive TuberculosisCompletedNCT03474198Phase 2/3
- Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)CompletedNCT03405064Phase 3
- Antimicrobial Treatment in Patients With Ventilator-associated TracheobronchitisTerminatedNCT03012360Phase 4
- Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and LevofloxacinWithdrawnNCT02975570Phase 3
- Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant TuberculosisCompletedNCT02778828Not applicable
- Evaluating Newly Approved Drugs for Multidrug-resistant TBCompletedNCT02754765Phase 3
- An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant TuberculosisCompletedNCT02454205Phase 2/3
- A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001)CompletedNCT02279875Phase 2
- Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)CompletedNCT02087566Not applicable
- Linezolid Instead of Ethambutol in Treatment of Drug-susceptible TuberculosisStatus unknownNCT01994460Phase 2
- Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With PneumoniaCompletedNCT01805284Phase 4
- Staphylococcus Aureus Bacteremia Antibiotic Treatment OptionsCompletedNCT01792804Phase 3
- Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint InfectionStatus unknownNCT01757236Phase 2
- A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose StudyCompletedNCT01554995Phase 1
- Effect of Linezolid on Ex Vivo Neutrophil and Monocyte Function in Healthy MalesCompletedNCT01544673Phase 1
- Population Pharmacokinetics of LinezolidCompletedNCT01200654Phase 4
- Safety, Tolerability, Pharmacokinetics And Measurement Of Whole Blood Activity (WBA) Of PNU-100480 After Multiple Oral Doses In Healthy Adult VolunteersCompletedNCT00990990Phase 1
- Study of Antibiotics in Cerebrospinal Fluid Following Intravenous InjectionWithdrawnNCT00925093Phase 1
- Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus AureusCompletedNCT00572559Phase 4
- Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive InfectionsCompletedNCT00501150Not applicable
- Study of Intravenous (I.V.) Iclaprim Versus Linezolid in Complicated Skin and Skin Structure Infections [cSSSI] (ASSIST-2)CompletedNCT00303550Phase 3
- Evaluation Of Linezolid Pk Profile In Burns PatientsCompletedNCT00255996Phase 1
- Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in JapanCompletedNCT00150332Phase 3
- Time To Efficacy and Onset Of Action Of LinezolidCompletedNCT00147511Phase 4
- Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive BacteriaCompletedNCT00037050Phase 3
- New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)CompletedNCT00035854Phase 3
- Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive InfectionCompletedNCT00035425Phase 3